147 related articles for article (PubMed ID: 16330479)
1. Mutant huntingtin alters MAPK signaling pathways in PC12 and striatal cells: ERK1/2 protects against mutant huntingtin-associated toxicity.
Apostol BL; Illes K; Pallos J; Bodai L; Wu J; Strand A; Schweitzer ES; Olson JM; Kazantsev A; Marsh JL; Thompson LM
Hum Mol Genet; 2006 Jan; 15(2):273-85. PubMed ID: 16330479
[TBL] [Abstract][Full Text] [Related]
2. CEP-1347 reduces mutant huntingtin-associated neurotoxicity and restores BDNF levels in R6/2 mice.
Apostol BL; Simmons DA; Zuccato C; Illes K; Pallos J; Casale M; Conforti P; Ramos C; Roarke M; Kathuria S; Cattaneo E; Marsh JL; Thompson LM
Mol Cell Neurosci; 2008 Sep; 39(1):8-20. PubMed ID: 18602275
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation of huntingtin by cyclin-dependent kinase 5 is induced by DNA damage and regulates wild-type and mutant huntingtin toxicity in neurons.
Anne SL; Saudou F; Humbert S
J Neurosci; 2007 Jul; 27(27):7318-28. PubMed ID: 17611284
[TBL] [Abstract][Full Text] [Related]
4. The serum- and glucocorticoid-induced kinase SGK inhibits mutant huntingtin-induced toxicity by phosphorylating serine 421 of huntingtin.
Rangone H; Poizat G; Troncoso J; Ross CA; MacDonald ME; Saudou F; Humbert S
Eur J Neurosci; 2004 Jan; 19(2):273-9. PubMed ID: 14725621
[TBL] [Abstract][Full Text] [Related]
5. Expression of full-length polyglutamine-expanded Huntingtin disrupts growth factor receptor signaling in rat pheochromocytoma (PC12) cells.
Song C; Perides G; Liu YF
J Biol Chem; 2002 Feb; 277(8):6703-7. PubMed ID: 11733534
[TBL] [Abstract][Full Text] [Related]
6. Expanded huntingtin activates the c-Jun terminal kinase/c-Jun pathway prior to aggregate formation in striatal neurons in culture.
Garcia M; Charvin D; Caboche J
Neuroscience; 2004; 127(4):859-70. PubMed ID: 15312898
[TBL] [Abstract][Full Text] [Related]
7. Mitogen- and stress-activated protein kinase-1 deficiency is involved in expanded-huntingtin-induced transcriptional dysregulation and striatal death.
Roze E; Betuing S; Deyts C; Marcon E; Brami-Cherrier K; Pagès C; Humbert S; Mérienne K; Caboche J
FASEB J; 2008 Apr; 22(4):1083-93. PubMed ID: 18029446
[TBL] [Abstract][Full Text] [Related]
8. Implication of the JNK pathway in a rat model of Huntington's disease.
Perrin V; Dufour N; Raoul C; Hassig R; Brouillet E; Aebischer P; Luthi-Carter R; Déglon N
Exp Neurol; 2009 Jan; 215(1):191-200. PubMed ID: 19022249
[TBL] [Abstract][Full Text] [Related]
9. Intersectin enhances huntingtin aggregation and neurodegeneration through activation of c-Jun-NH2-terminal kinase.
Scappini E; Koh TW; Martin NP; O'Bryan JP
Hum Mol Genet; 2007 Aug; 16(15):1862-71. PubMed ID: 17550941
[TBL] [Abstract][Full Text] [Related]
10. Functional gene expression profiling in yeast implicates translational dysfunction in mutant huntingtin toxicity.
Tauber E; Miller-Fleming L; Mason RP; Kwan W; Clapp J; Butler NJ; Outeiro TF; Muchowski PJ; Giorgini F
J Biol Chem; 2011 Jan; 286(1):410-9. PubMed ID: 21044956
[TBL] [Abstract][Full Text] [Related]
11. ATF3 plays a protective role against toxicity by N-terminal fragment of mutant huntingtin in stable PC12 cell line.
Liang Y; Jiang H; Ratovitski T; Jie C; Nakamura M; Hirschhorn RR; Wang X; Smith WW; Hai T; Poirier MA; Ross CA
Brain Res; 2009 Aug; 1286():221-9. PubMed ID: 19559011
[TBL] [Abstract][Full Text] [Related]
12. Dithiol-based compounds maintain expression of antioxidant protein peroxiredoxin 1 that counteracts toxicity of mutant huntingtin.
Pitts A; Dailey K; Newington JT; Chien A; Arseneault R; Cann T; Thompson LM; Cumming RC
J Biol Chem; 2012 Jun; 287(27):22717-29. PubMed ID: 22577145
[TBL] [Abstract][Full Text] [Related]
13. Mutant huntingtin enhances excitotoxic cell death.
Zeron MM; Chen N; Moshaver A; Lee AT; Wellington CL; Hayden MR; Raymond LA
Mol Cell Neurosci; 2001 Jan; 17(1):41-53. PubMed ID: 11161468
[TBL] [Abstract][Full Text] [Related]
14. Depletion of CBP is directly linked with cellular toxicity caused by mutant huntingtin.
Jiang H; Poirier MA; Liang Y; Pei Z; Weiskittel CE; Smith WW; DeFranco DB; Ross CA
Neurobiol Dis; 2006 Sep; 23(3):543-51. PubMed ID: 16766198
[TBL] [Abstract][Full Text] [Related]
15. Huntingtin phosphorylation sites mapped by mass spectrometry. Modulation of cleavage and toxicity.
Schilling B; Gafni J; Torcassi C; Cong X; Row RH; LaFevre-Bernt MA; Cusack MP; Ratovitski T; Hirschhorn R; Ross CA; Gibson BW; Ellerby LM
J Biol Chem; 2006 Aug; 281(33):23686-97. PubMed ID: 16782707
[TBL] [Abstract][Full Text] [Related]
16. Effects of mutant huntingtin on mGluR5-mediated dual signaling pathways: implications for therapeutic interventions.
Huang SS; He J; Zhao DM; Xu XY; Tan HP; Li H
Cell Mol Neurobiol; 2010 Oct; 30(7):1107-15. PubMed ID: 20644995
[TBL] [Abstract][Full Text] [Related]
17. Unraveling a role for dopamine in Huntington's disease: the dual role of reactive oxygen species and D2 receptor stimulation.
Charvin D; Vanhoutte P; Pagès C; Borrelli E; Caboche J
Proc Natl Acad Sci U S A; 2005 Aug; 102(34):12218-23. PubMed ID: 16103364
[TBL] [Abstract][Full Text] [Related]
18. Effects of intracellular expression of anti-huntingtin antibodies of various specificities on mutant huntingtin aggregation and toxicity.
Khoshnan A; Ko J; Patterson PH
Proc Natl Acad Sci U S A; 2002 Jan; 99(2):1002-7. PubMed ID: 11792860
[TBL] [Abstract][Full Text] [Related]
19. Type 2 transglutaminase differentially modulates striatal cell death in the presence of wild type or mutant huntingtin.
Ruan Q; Quintanilla RA; Johnson GV
J Neurochem; 2007 Jul; 102(1):25-36. PubMed ID: 17403029
[TBL] [Abstract][Full Text] [Related]
20. A novel target for Huntington's disease: ERK at the crossroads of signaling. The ERK signaling pathway is implicated in Huntington's disease and its upregulation ameliorates pathology.
Bodai L; Marsh JL
Bioessays; 2012 Feb; 34(2):142-8. PubMed ID: 22334892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
